calotropin has been researched along with cannogenol-3-o-beta-d-allomethyloside in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abou-Tarboush, FM; AbulFarah, M; Al-Anazi, FS; Al-Anazi, KM; Al-Hemaid, F; Ali, MA; Bhattacharjee, A; Gurung, AB; Lee, J | 1 |
1 other study(ies) available for calotropin and cannogenol-3-o-beta-d-allomethyloside
Article | Year |
---|---|
Molecular docking of the anticancer bioactive compound proceraside with macromolecules involved in the cell cycle and DNA replication.
Topics: Antineoplastic Agents; Cardenolides; Cardiac Glycosides; Cell Cycle; Cell Line, Tumor; Digitoxigenin; DNA Replication; Humans; Ligands; Macromolecular Substances; Molecular Docking Simulation; Structure-Activity Relationship | 2016 |